" class="no-js "lang="en-US"> Lubor Gaal - Medtech Alert
Friday, November 08, 2024
Lubor Gaal

Lubor Gaal

About Lubor Gaal

Over 20 years of business development, External Innovation and licensing experience in biotechnology and BioPharma companies. Successful transaction track record in securing assets and finding creative solutions for licensing and partnering transactions, collaborations or in and out-licensing. Senior negotiator or transaction advisor on complex asset transactions or research collaboration. Successful biotech entrepreneur with successful outlicensing transactions and fundraising from VC investors with two different biotech companies. Extensive global network of senior executives in Pharma or Biotech companies and VC investors.

Related Story

Targovax ASA Strengthens Management with Lubor Gaal as Chief Financial Officer

February 28 2022

Targovax ASA (OSE: TRVX) a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid […]